วีดีโอ

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Questions 10 and 11 of the CASP RCT Checklist, “Can the results be applied to your local population/ in your context?” and “Would the experimental intervention provide greater value to the people in your care than any of the existing interventions?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishi...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 9 of the CASP RCT Checklist,“Do the benefits of the experimental intervention outweigh the harms and costs?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patient...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 8 of the CASP RCT Checklist,“Was the precision of the estimate of the intervention or treatment effect reported?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese pa...

Barts Health Knowledge and Library Services’ Adam Tocock goes through Question 7 of the CASP checklist: “Were the effects of intervention reported comprehensively?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to ...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 6 of the CASP RCT Checklist,“Apart from the experimental intervention, did each study group receive the same level of care (that is, were they treated equally)?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-control...

Barts Health Knowledge and Library Services’ Adam Tocock goes through Question 5 of the CASP checklist, “Were the study groups similar at the start of the randomised controlled trial?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients wi...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 4 of the CASP RCT Checklist, “Were patients, health workers and study personnel blinded?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain du...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 3 of the CASP RCT Checklist, “Were all participants who entered the study accounted for at its conclusion?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients...

Barts Health Knowledge and Library Services’ Adam Tocock goes through Question 2 of the CASP RCT Checklist, “Was the assignment of participants to interventions randomised?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pai...

Barts Health Knowledge and Library Services’ Assad Lahlou goes through Question 1 of the CASP RCT Checklist, “Did the study address a clear focus question?” in relation to the following paper: Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoart...